QDIS Blog

I mentioned in a previous post that R&D directions magazine had a cover story entitled “From Pipeline to Market” about the state of drug development and I gave a few numbers from that in terms of the number of drugs being developed for various indications.

Now, the trade magazine Contract Pharma has their cover stories “Top 20 Pharmaceutical Companies” and “Top 10 Biotech Companies“. Both of these are gold mines if you want to know who is doing what and how well is each drug is doing. Kudos to Contract Pharma for putting this together. The companies are ranked on the basis of revenues.

Here is a sampling of what is included for each pharmaceutical company; headcount, total revenue (and the change from the previous year), net income, and R&D Budget. For each company it also lists drugs approved/launched, those pending approval, those in phase II and beyond, and drugs coming off patent. They also list the sales and percent change for each companies top selling drugs.

Just for the record, here’s the lists:

Top 20 Pharmaceutical Companies

1. Pfizer
2. Sanofi-Aventis
3. GlaxoSmithKline
4. AstraZeneca
5. Johnson & Johnson
6. Merck
7. Novartis
8. Roche
9. Bristol-Myers Squibb
10. Wyeth
11. Eli lilly
12. Abbott
13. Boehringer-Ingelheim
14. Takeda
15. Schering-Plough
16. Astellas Pharma
17. Daiichi-Sankyo
18. Novo Nodisk
19. Eisai
20. Bayer AG

Top 10 Biotech Companies

1. Amgen
2. Genentech
3. Serono
4. Biogen Idec
5. Gilead Sciences
6. Genzyme
7. MedImmune
8. Chiron (now part of Novartis)
9. Millennium Pharma
10. ImClone

Technorati Tags: biotech companies, pharmaceutical companies, pharma stats

Email Ed Vawter

Bookmark it with: | del.icio.us | Digg it | Furl | Simpy | Spurl | My Yahoo! |